Advertisement
Screener

SPECTRAL AI, INC. (MDAI) APIC, Share-based Payment Arrangement, Increase for Cost Recognition

SPECTRAL AI, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition

SPECTRAL AI, INC. (MDAI) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.24 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-29.

Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2024-03-29

  • SPECTRAL AI, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-12-31 was $268.00K.
  • SPECTRAL AI, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-09-30 was $279.00K, a 12.96% increase year-over-year.
  • SPECTRAL AI, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-06-30 was $396.00K, a 34.69% increase year-over-year.
  • SPECTRAL AI, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-03-31 was $300.00K, a 9.91% decline year-over-year.
  • SPECTRAL AI, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $1.24M, a 7.62% increase from fiscal 2022.
  • SPECTRAL AI, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $1.16M.
Period endAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month
2023-12-31$268.00K
derived: 10-K 12 month − 3 quarters · filed 2024-03-29
$547.00K
derived: sum of 2 quarters · filed 2024-03-29
$943.00K
derived: sum of 3 quarters · filed 2024-03-29
$1.24M
10-K · filed 2024-03-29
2023-09-30$279.00K
10-Q · filed 2023-11-14
$675.00K
derived: sum of 2 quarters · filed 2023-11-14
$975.00K
derived: sum of 3 quarters · filed 2023-11-14
2023-06-30$396.00K
10-Q · filed 2023-11-14
$696.00K
derived: sum of 2 quarters · filed 2023-11-14
2023-03-31$300.00K
10-Q · filed 2023-11-14
2022-12-31$1.16M
10-K · filed 2024-03-29
2022-09-30$247.00K
10-Q · filed 2023-11-14
$541.00K
derived: sum of 2 quarters · filed 2023-11-14
$874.00K
derived: sum of 3 quarters · filed 2023-11-14
2022-06-30$294.00K
10-Q · filed 2023-11-14
$627.00K
derived: sum of 2 quarters · filed 2023-11-14
2022-03-31$333.00K
10-Q · filed 2023-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
TELA Bio, Inc. (TELA)United States$0.057B-0.82
NEPHROS INC (NEPH)United States$0.046B23.02
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
DarioHealth Corp. (DRIO)$0.066B-1.39
CVRx, Inc. (CVRX)United States$0.067B-2.62
InspireMD, Inc. (NSPR)$0.033B
PAVmed Inc. (PAVM)United States$0.031B-3.00
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18